Shanghai Golden Leaf Med Tech(Brattea), a beacon of innovation in the medical device industry since 2013. Located in the vibrant Xuhui District of Shanghai, within the prestigious Juke Biopark.
We are at the forefront of pioneering minimally invasive interventional therapies. Our extensive portfolio of intellectual property rights underscores our commitment to delivering unparalleled medical solutions through a seamless integration of R&D, production, and sales.
Our team comprises top-tier professionals with rich experience from esteemed academic and medical institutions worldwide, ensuring that our offerings are both groundbreaking and reliable. Our collaborations with leading medical experts, universities, and hospitals globally reflect our dedication to excellence.
Brattea is dedicated to expanding and optimizing its energy platform, incorporating various active energy technologies such as Radio Frequency (RF), Ultrasound (US), and Pulsed Field Ablation (PFA) specifically designed for different anatomies. We are actively advancing into multiple chronic disease areas, including hypertension, diabetes, COPD, and heart failure, utilizing minimally invasive technologies to address treatment challenges associated with medications that are ineffective, have poor compliance, or cannot provide a cure.
Our goal is to improve treatment success rates and significantly reduce the incidence of life-threatening and disabling conditions.
